{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:11:23Z","timestamp":1787793083515,"version":"build-2784847793"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T00:00:00Z","timestamp":1731196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.nbd.2024.106734","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T20:56:34Z","timestamp":1731444994000},"page":"106734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The broad spectrum of malignant syndromes"],"prefix":"10.1016","volume":"203","author":[{"given":"Martina","family":"Cuccarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zampogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Suppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2024.106734_bb0005","first-page":"1139","article-title":"Prevention, recognition, and management of serotonin syndrome","volume":"81","author":"Ables","year":"2010","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.nbd.2024.106734_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/dmcn.12339","article-title":"Status dystonicus: a practice guide","volume":"56","author":"Allen","year":"2014","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.nbd.2024.106734_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-229122","article-title":"Malignant deep brain stimulator withdrawal syndrome","volume":"12","author":"Azar","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.nbd.2024.106734_bb0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccc.2021.03.002","article-title":"Drugs of abuse: sympathomimetics","volume":"37","author":"Brown","year":"2021","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.nbd.2024.106734_bb0025","article-title":"Why is there motor deterioration in Parkinson\u2019s disease during systemic infections-a hypothetical view","volume":"1","author":"Brugger","year":"2015","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.nbd.2024.106734_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0447.1996.tb09814.x","article-title":"Catatonia. I. Rating scale and standardized examination","volume":"93","author":"Bush","year":"1996","journal-title":"Acta Psychiatr. Scand."},{"issue":"Suppl 4","key":"10.1016\/j.nbd.2024.106734_bb0035","first-page":"12","article-title":"Movement disorders associated with atypical antipsychotic drugs","volume":"63","author":"Caroff","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106734_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/08850666221114303","article-title":"Malignant catatonia: a review for the intensivist","volume":"38","author":"Connell","year":"2023","journal-title":"J. Intensive Care Med."},{"key":"10.1016\/j.nbd.2024.106734_bb0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000506868","article-title":"Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications","volume":"89","author":"Cosci","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.nbd.2024.106734_bb0050","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.1073\/pnas.1800490115","article-title":"Junctional membrane ca 2+ dynamics in human muscle fibers are altered by malignant hyperthermia causative RyR mutation","volume":"115","author":"Cully","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2024.106734_bb0055","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/bcp.12839","article-title":"Pharmacological management of anticholinergic delirium - theory, evidence and practice: anticholinergic delirium","volume":"81","author":"Dawson","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.nbd.2024.106734_bb0060","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1210\/en.2008-0038","article-title":"Hypermetabolic syndrome as a consequence of repeated psychological stress in mice","volume":"149","author":"Depke","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.nbd.2024.106734_bb0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-2007-1017097","article-title":"Neuroleptic malignant syndrome: observations on altered consciousness","volume":"20","author":"Deuschl","year":"1987","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.nbd.2024.106734_bb0070","article-title":"Dyskinesia-hyperpyrexia syndrome in Parkinson\u2019s disease triggered by overdose of levodopa - a case report and literature review","volume":"14","author":"Du","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2024.106734_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.anclin.2019.10.010","article-title":"Malignant hyperthermia update","volume":"38","author":"Ellinas","year":"2020","journal-title":"Anesthesiol. Clin."},{"key":"10.1016\/j.nbd.2024.106734_bb0080","article-title":"Gastrointestinal symptoms as an autonomic manifestation in serotonin syndrome","volume":"3","author":"Faisal","year":"2024","journal-title":"Psychiatry Res. Case Rep."},{"key":"10.1016\/j.nbd.2024.106734_bb0085","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/01.pec.0000227388.91885.4b","article-title":"Heatstroke in the super-sized athlete: Pediatr","volume":"22","author":"Fink","year":"2006","journal-title":"Emerg. Care"},{"key":"10.1016\/j.nbd.2024.106734_bb0090","first-page":"720","article-title":"Demystifying serotonin syndrome (or serotonin toxicity)","volume":"64","author":"Foong","year":"2018","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.nbd.2024.106734_bb0095","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3390\/ijms20092288","article-title":"The serotonin syndrome: from molecular mechanisms to clinical practice","volume":"20","author":"Francescangeli","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2024.106734_bb0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0310057X1504300204","article-title":"Analysis of the entire ryanodine receptor type 1 and alpha 1 subunit of the Dihydropyridine receptor (CACNA1S) coding regions for variants associated with malignant hyperthermia in Australian families","volume":"43","author":"Gillies","year":"2015","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.nbd.2024.106734_bb0105","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/mds.23220","article-title":"Neuroleptic malignant syndrome: mechanisms, interactions, and causality: neuroleptic malignant syndrome","volume":"25","author":"Gillman","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106734_bb0110","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/ALN.0b013e3182a8a8e7","article-title":"Using exome data to identify malignant hyperthermia susceptibility mutations","volume":"119","author":"Gonsalves","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nbd.2024.106734_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.annemergmed.2024.02.016","article-title":"Managing alcohol withdrawal syndrome","volume":"84","author":"Gottlieb","year":"2024","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.nbd.2024.106734_bb0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/TME.0000000000000344","article-title":"Pathophysiology and treatment of malignant hyperthermia","volume":"43","author":"Gregory","year":"2021","journal-title":"Adv. Emerg. Nurs. J."},{"key":"10.1016\/j.nbd.2024.106734_bb0125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neurom.2022.09.008","article-title":"Deep brain stimulation-withdrawal syndrome in Parkinson\u2019s disease: risk factors and pathophysiological hypotheses of a life-threatening emergency","volume":"26","author":"Grimaldi","year":"2023","journal-title":"Neuromodul. J. Int. Neuromodul. Soc."},{"key":"10.1016\/j.nbd.2024.106734_bb0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/ajp.156.2.169","article-title":"Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome","volume":"156","author":"Gurrera","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106734_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/JCP.0000000000000640","article-title":"A validation study of the international consensus diagnostic criteria for neuroleptic malignant syndrome","volume":"37","author":"Gurrera","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.nbd.2024.106734_bb0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1523\/JNEUROSCI.3483-12.2013","article-title":"Physostigmine and galanthamine bind in the presence of agonist at the canonical and noncanonical subunit interfaces of a nicotinic acetylcholine receptor","volume":"33","author":"Hamouda","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2024.106734_bb0145","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccc.2012.07.008","article-title":"Toxidromes","volume":"28","author":"Holstege","year":"2012","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.nbd.2024.106734_bb0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.18773\/austprescr.2019.006","article-title":"The hot patient: acute drug-induced hyperthermia","volume":"42","author":"Jamshidi","year":"2019","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.nbd.2024.106734_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ane.12671","article-title":"Alcohol withdrawal syndrome: mechanisms, manifestations, and management","volume":"135","author":"Jesse","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2024.106734_bb0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbabio.2018.11.007","article-title":"Uncoupling mechanism and redox regulation of mitochondrial uncoupling protein 1 (UCP1)","volume":"1860","author":"Je\u017eek","year":"2019","journal-title":"Biochim. Biophys. Acta BBA - Bioenerg."},{"key":"10.1016\/j.nbd.2024.106734_bb0165","doi-asserted-by":"crossref","DOI":"10.1017\/S1461145701002723","article-title":"Serotonin syndrome \u2013 \u2018potential\u2019 role of the CYP2D6 genetic polymorphism in Asians","volume":"5","author":"Kaneda","year":"2002","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2024.106734_bb0170","first-page":"154","article-title":"Malignant hyperthermia","volume":"116","author":"Kaur","year":"2019","journal-title":"Mo. Med."},{"key":"10.1016\/j.nbd.2024.106734_bb0175","series-title":"Transforming Growth Factor- Directly Augments Histidine Decarboxylase and Vesicular Monoamine Transporter 2 Production in Rat Enterochromaffin-like Cells","first-page":"286","author":"Kazumori","year":"2004"},{"key":"10.1016\/j.nbd.2024.106734_bb0180","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3390\/children9111692","article-title":"Malignant hyperthermia in PICU\u2014from diagnosis to treatment in the light of up-to-date knowledge","volume":"9","author":"Klincov\u00e1","year":"2022","journal-title":"Children"},{"key":"10.1016\/j.nbd.2024.106734_bb0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-9-8","article-title":"Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-Centre study","volume":"9","author":"Klingler","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.nbd.2024.106734_bb0190","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1399-5618.2008.00598.x","article-title":"Serotonin syndrome and the T 102 C polymorphism of the 5-HT 2A receptor: a case report","volume":"10","author":"Lattanzi","year":"2008","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.nbd.2024.106734_bb0195","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1213\/ANE.0b013e3182768f99","article-title":"Death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old","volume":"116","author":"Lavezzi","year":"2013","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.nbd.2024.106734_bb0200","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/jamaneurol.2017.0822","article-title":"Confusing terminology-neuroleptic malignant syndrome vs malignant hyperthermia","volume":"74","author":"Litman","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2024.106734_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105438","article-title":"The changing face of reported status dystonicus - a systematic review","volume":"112","author":"Lumsden","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2024.106734_bb0210","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.psyneuen.2005.03.014","article-title":"Stress hormones in health and illness: the roles of work and gender","volume":"30","author":"Lundberg","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.nbd.2024.106734_bb0215","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00213-021-05876-x","article-title":"Serotonin toxicity of serotonergic psychedelics","volume":"239","author":"Malcolm","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2024.106734_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102046","article-title":"Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis: a multinational, retrospective cohort study","volume":"61","author":"Marti-Aguado","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.nbd.2024.106734_bb0225","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/pn-2022-003605","article-title":"Anticholinergic syndrome: blurred vision and headache","volume":"23","author":"McAnena","year":"2023","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.nbd.2024.106734_bb0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.18773\/austprescr.2006.068","article-title":"Psychostimulant poisoning","volume":"29","author":"McCormack","year":"2006","journal-title":"Aust. Prescr."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2024.106734_bb0235","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1353-8020(02)00125-6","article-title":"Malignant syndrome in Parkinson\u2019s disease: concept and review of the literature","volume":"9","author":"Mizuno","year":"2003","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2024.106734_bb0240","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1176\/appi.ajp.160.10.1830","article-title":"Pharmacogenetics of antidepressant medication intolerance","volume":"160","author":"Murphy","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106734_bb0245","article-title":"Successful diagnosis of neuroleptic malignant syndrome in an unconscious patient using amplitude-integrated electroencephalography: a case report","volume":"16","author":"Nakamura","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.nbd.2024.106734_bb0250","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2147\/NDT.S50244","article-title":"Increased biogenic catecholamine and metabolite levels in two patients with malignant catatonia","volume":"9","author":"Nisijima","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.nbd.2024.106734_bb0255","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0079-6123(06)62006-2","article-title":"Neuroleptic malignant syndrome and serotonin syndrome","volume":"162","author":"Nisijima","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2024.106734_bb0260","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S0140525X02000109","article-title":"What catatonia can tell us about \u201ctop-down modulation\u201d: a neuropsychiatric hypothesis","volume":"25","author":"Northoff","year":"2002","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.nbd.2024.106734_bb0265","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13181-014-0451-y","article-title":"Prevalence of rhabdomyolysis in sympathomimetic toxicity: a comparison of stimulants","volume":"11","author":"O\u2019Connor","year":"2015","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.nbd.2024.106734_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43045-020-00081-6","article-title":"Neuroleptic malignant syndrome: clinical expression, complication, course, and atypical clinical picture","volume":"28","author":"Oneib","year":"2021","journal-title":"Middle East Curr. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106734_bb0275","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1212\/01.WNL.0000157058.17871.7B","article-title":"Acute akinesia in Parkinson disease","volume":"64","author":"Onofrj","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2024.106734_bb0280","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1016\/S1353-8020(09)70821-1","article-title":"Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment","volume":"15","author":"Onofrj","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2024.106734_bb0285","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.10635","article-title":"The genetic foundations of serotonin syndrome, neuroleptic malignant syndrome, and malignant hyperthermia: is there a genetic association between these disorders?","author":"Ortiz","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.nbd.2024.106734_bb0290","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.2174\/138161211798220918","article-title":"Cytokine signaling modulates blood-brain barrier function","volume":"17","author":"Pan","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2024.106734_bb0295","article-title":"Serotonin toxicity and cytochrome p450 poor metaboliser genotype patient case","volume":"4","author":"Piatkov","year":"2017","journal-title":"J. Investig. Genomics"},{"key":"10.1016\/j.nbd.2024.106734_bb0300","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.mehy.2005.05.037","article-title":"Drugs of anesthesia acting on central cholinergic system may cause post-operative cognitive dysfunction and delirium","volume":"65","author":"Pratic\u00f2","year":"2005","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.nbd.2024.106734_bb0305","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/mds.25532","article-title":"Emerging concepts in the physiological basis of dystonia: emerging concepts in the basis of dystonia","volume":"28","author":"Quartarone","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106734_bb0310","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-0038-1677050","article-title":"Movement disorders emergencies","volume":"39","author":"Rajan","year":"2019","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.nbd.2024.106734_bb0315","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.parkreldis.2018.06.035","article-title":"Life-threatening DBS withdrawal syndrome in Parkinson\u2019s disease can be treated with early reimplantation","volume":"56","author":"Reuter","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2024.106734_bb0320","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211022197","article-title":"Baclofen therapeutics, toxicity, and withdrawal: a narrative review","volume":"9","author":"Romito","year":"2021","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.nbd.2024.106734_bb0325","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12028-010-9422-6","article-title":"Acute intrathecal baclofen withdrawal: a brief review of treatment options","volume":"14","author":"Ross","year":"2011","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.nbd.2024.106734_bb0330","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/mds.27207","article-title":"Rethinking status dystonicus: status dystonicus","volume":"32","author":"Ruiz-Lopez","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106734_bb0335","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1097\/CCM.0000000000000053","article-title":"Catatonia in the ICU: an important and underdiagnosed cause of altered mental status. A case series and review of the literature*","volume":"42","author":"Saddawi-Konefka","year":"2014","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.nbd.2024.106734_bb0340","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/08830738221081593","article-title":"Status dystonicus in children: a cross-sectional study and review of literature","volume":"37","author":"Saini","year":"2022","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.nbd.2024.106734_bb0345","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/mdc3.12663","article-title":"Dyskinesia-hyperpyrexia syndrome in Parkinson\u2019s disease: a heat shock-related emergency?","volume":"5","author":"Sarchioto","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.nbd.2024.106734_bb0350","series-title":"Basic Anesthesia Review","article-title":"Reticular activating system","author":"Shah","year":"2024"},{"key":"10.1016\/j.nbd.2024.106734_bb0355","first-page":"97","article-title":"Series of seizures as a sign of development of recurrent malignant neuroleptic syndrome - a case report","volume":"18","author":"Supe","year":"2006","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.nbd.2024.106734_bb0360","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1176\/appi.ajp.158.10.1714","article-title":"Association of the Taq I a Polymorphism of the dopamine D 2 receptor gene with predisposition to neuroleptic malignant syndrome","volume":"158","author":"Suzuki","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106734_bb0365","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3390\/ijms24021352","article-title":"Mitochondrial energy metabolism in the regulation of thermogenic brown fats and human metabolic diseases","volume":"24","author":"Takeda","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2024.106734_bb0370","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/14740338.2021.1919622","article-title":"Malignant syndromes: current advances","volume":"20","author":"Tao","year":"2021","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.nbd.2024.106734_bb0375","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40734-017-0057-z","article-title":"Dystonic storm: a practical clinical and video review","volume":"4","author":"Termsarasab","year":"2017","journal-title":"J. Clin. Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106734_bb0380","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/B978-0-444-64074-1.00039-2","article-title":"Neuroleptic malignant syndrome and serotonin syndrome","author":"Tormoehlen","year":"2018"},{"key":"10.1016\/j.nbd.2024.106734_bb0385","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159X13999150424113345","article-title":"Neuroleptic malignant syndrome: a review from a clinically oriented perspective","volume":"13","author":"Tse","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.nbd.2024.106734_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261443","article-title":"Alcohol withdrawal syndrome in ICU patients: clinical features, management, and outcome predictors","volume":"16","author":"Vigouroux","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2024.106734_bb0395","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1073\/pnas.0501650102","article-title":"Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation","volume":"102","author":"Viswanathan","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2024.106734_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29794","article-title":"Recommendations for the management of initial and refractory pediatric status dystonicus","author":"Vogt","year":"2024","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.nbd.2024.106734_bb0405","article-title":"Measuring catatonia motor behavior with objective instrumentation","volume":"13","author":"Von K\u00e4nel","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.nbd.2024.106734_bb0410","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2215-0366(18)30474-7","article-title":"Structure and neural mechanisms of catatonia","volume":"6","author":"Walther","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.nbd.2024.106734_bb0415","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10286-021-00801-w","article-title":"Dyskinesia-hyperpyrexia syndrome in Parkinson\u2019s disease: a systematic review","volume":"31","author":"Wang","year":"2021","journal-title":"Clin. Auton. Res. Off. J. Clin. Auton. Res. Soc."},{"key":"10.1016\/j.nbd.2024.106734_bb0420","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3233\/JPD-223362","article-title":"Parkinsonism-hyperpyrexia syndrome and dyskinesia-hyperpyrexia syndrome in Parkinson\u2019s disease: two cases and literature review","volume":"12","author":"Wang","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2024.106734_bb0425","doi-asserted-by":"crossref","DOI":"10.4088\/PCC.17r02185","article-title":"Neuroleptic malignant syndrome: diagnosis and management","volume":"20","author":"Ware","year":"2018","journal-title":"Prim. Care Companion CNS Disord."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612400336X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612400336X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T06:39:54Z","timestamp":1736231994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999612400336X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":85,"alternative-id":["S096999612400336X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106734","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The broad spectrum of malignant syndromes","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106734"}}